Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,565 | -23,086 | -73,740 | -47,507 | -26,748 |
| Depreciation Amortization | 1,972 | 998 | 3,352 | 2,462 | 1,524 |
| Income taxes - deferred | N/A | N/A | -1 | N/A | N/A |
| Accounts receivable | 7,858 | 5,472 | -9,237 | -10,122 | -3,033 |
| Other Working Capital | -12,864 | -1,264 | -529 | -3,521 | -1,750 |
| Other Operating Activity | 3,652 | 2,653 | 17,600 | 11,036 | 997 |
| Operating Cash Flow | $-31,947 | $-15,227 | $-62,555 | $-47,652 | $-29,010 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,573 | 18,957 | 19,210 | 9,226 | -323 |
| PPE Investments | -5,828 | -789 | -2,739 | -2,672 | -2,197 |
| Purchase Sale Intangibles | N/A | N/A | -200 | -200 | -200 |
| Other Investing Activity | 0 | 0 | -200 | -200 | -200 |
| Investing Cash Flow | $11,745 | $18,168 | $16,272 | $6,354 | $-2,720 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 24,926 | 826 | 7,937 | 7,066 | 2,697 |
| Other Financing Activity | 0 | 0 | -150 | -150 | -150 |
| Financing Cash Flow | $24,926 | $826 | $7,787 | $6,917 | $2,547 |
| Beginning Cash Position | 19,137 | 19,137 | 57,633 | 57,633 | 57,633 |
| End Cash Position | 23,861 | 22,903 | 19,137 | 23,251 | 28,450 |
| Net Cash Flow | $4,724 | $3,767 | $-38,496 | $-34,382 | $-29,182 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,947 | -15,227 | -62,555 | -47,652 | -29,010 |
| Capital Expenditure | -5,828 | -789 | -2,739 | -2,672 | -2,197 |
| Free Cash Flow | -37,775 | -16,017 | -65,294 | -50,324 | -31,207 |